Cardiovascular involvement in Epstein-Barr virus infection

Xinying Chen1, Yingying Li2, Lijun Deng1,2

  • 1Department of Pediatrics, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.

PubMed

Insights

Cardiovascular complications from Epstein-Barr virus (EBV) infection, including coronary artery issues and myocarditis, are severe but rare. Prompt diagnosis and treatment are crucial for better outcomes in EBV-related heart damage.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Immunology

Background:

  • Epstein-Barr virus (EBV) infection can lead to uncommon but severe cardiovascular complications.
  • These complications, including coronary artery dilation (CAD) and myocarditis, have a poor prognosis if not managed promptly.
  • Current understanding and clinical guidance for EBV-associated cardiovascular damage are limited.

Purpose of the Study:

  • To synthesize current knowledge on cardiovascular damage associated with EBV infection.
  • To provide an overview of the pathogenesis, classification, treatment, and prognosis of these complications.
  • To enhance clinical recognition and management of EBV-related cardiovascular issues.

Main Methods:

  • Review of existing literature on cardiovascular manifestations of Epstein-Barr virus infection.
  • Synthesis of data regarding pathogenesis, clinical presentation, and diagnostic approaches.
  • Compilation of current treatment strategies and prognostic factors.

Main Results:

  • Cardiovascular involvement in EBV infection presents diverse manifestations like CAD, coronary artery aneurysm (CAA), myocarditis, arrhythmias, and heart failure.
  • Untreated cardiovascular damage can progress, leading to significant mortality.
  • There is a need for more large-scale data and evidence-based guidelines for effective management.

Conclusions:

  • Cardiovascular complications of EBV infection require increased clinical attention due to their severity and potential for poor outcomes.
  • Early diagnosis and intervention are key to improving prognosis and reducing mortality.
  • This review aims to support clinicians in recognizing and managing these challenging cases.

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
14
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
17
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
16